Table 2: Distribution of analyzed HSIL specimens with respect to HPV infection type (as assessed via REBA).

HPV infection typeN (%)

HPV-positive HSIL
N = 83/104
(79.81)
Single HPV infectionHR-HPV56/104 (53.85)
N = 57/104 (54.81)LR-HPV1/104 (0.96)
Multiple HPV infections
N = 26/104 (25)
HR-HPV21/104 (20.19)
LR-HPV0/104 (0)
HR- & LR-HPV infections5/104 (4.81)
HPV-negative HSIL21/104 (20.19)

HPV: human papillomavirus; REBA: reverse-blot hybridization assay; HSIL: high-grade squamous intraepithelial lesion; HR-HPV: high-risk HPV; LR-HPV: low-risk HPV.